Bayer Unit Gets FDA Hepatitis Test OK
June 7, 2005
On Monday, the diagnostics division of Bayer AG announced the U.S. Food and Drug Administration approved two of its automated hepatitis B tests. Bayer's Healthcare Diagnostics division said the first test detects the presence of hepatitis B virus (HBV) in the blood, and the second test confirms the results to diagnose acute or chronic HBV infection. The approval gives Bayer eight unique types of hepatitis tests that can be used on the company's ADVIA Centaur automatic testing machine. Bayer now has a complete testing panel for hepatitis types A, B, and C, the company noted. HBV is the most common and serious of all liver infections. Infecting an estimated 2 billion people worldwide, HBV and its complications claim the lives of 1 million each year, said Bayer.
California: 1,600 Set Out on 2 Wheels for Weeklong AIDS Ride, Additional 400 Tag Along With Cyclists on 585-Mile Trek
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.